High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer
Meng Zhang(First Affiliated Hospital of Zhengzhou University), Zhenhe Suo(Oslo University Hospital), Shuzheng Liu(Zhengzhou University), Zhirui Fan(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Huijie Fan(Shanxi University), Huixiang Li(Zhengzhou University), Jing Zhao(University of Electronic Science and Technology of China), Xiaoli Li(Fujian Medical University), Mariusz Adam Goscinski(Oslo University Hospital)
Cited by 14
Related Papers
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
|Journal of Cellular Physiology|2019|115